Kim Chi, MD

Dr. Chi is a medical oncologist, Executive Vice President and Chief Medical Officer of BC Cancer and the Provincial Health Services Authority, which oversees a comprehensive cancer control program for the people of British Columbia (BC), in Canada. He is also Professor in the Faculty of Medicine at the University of British Columbia, a Professor in the Faculty of Health Sciences at Simon Fraser University, and the Shrum Chair in Prostate Cancer Research at BC Cancer. Dr. Chi's research in the field of genitourinary cancers focuses on prostate cancer and investigational new drugs, where he has contributed to changing international standards of care practice for patients with advanced prostate cancer. He also has been investigating circulating tumour DNA as a source of prognostic and predictive biomarkers for patients with metastatic prostate cancer. Dr. Chi is the past-Chair of the Genitourinary Disease and Investigational New Drugs Site Committees with the Canadian Cancer Trials Group, and has held peer-reviewed grant funding from the Canada Institutes of Health Research (CIHR), National Cancer Institute of Canada (NCIC)/Canadian Cancer Society (CCS), the US Department of Defence, Movember, Prostate Cancer Foundation (USA), and Prostate Cancer Canada.